Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07524738) titled 'Telemedicine XR-B for Individuals in Jail' on April 6.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Friends Research Institute, Inc.

Condition: Opioid Use Disorder

Intervention: Drug: Extended Release Buprenorphine

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: June 1, 2025

Target Sample Size: 30

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07524738

Published by HT Digital Content ...